We would like to maintain an open and continuous dialogue with our investors, the media and the general public. If you have questions or need further information, please contact us.
South Rampart Pharma hopes to be in the clinic by Q3 2020. Check back here for more updates on the clinical status of SRP compounds and for details about participating in one of our clinical trials.
South Rampart Pharma looks forward to partnering with a highly committed company to bring its important non-opioid pain medicines to the market as soon as possible, in consultation with FDA and EMA, in order to provide a solution for this growing unmet need.
South Rampart Pharma is looking for pharma partners that have deep and broad experience developing and commercializing drugs safely and successfully, as well as an in depth understanding of chronic, acute and neuropathic pain.
If you have questions or need further information regarding partnering and business development opportunities, please contact us.
South Rampart Pharma
478 Broadway Street
New Orleans, LA 70118
© 2020 South Rampart Pharma.